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Abstract
Background: Human decidual stromal cells (DSCs) are involved in the maintenance and development of
pregnancy, in which they play a key role in the induction of immunological maternal–fetal tolerance. Precursors of
DSCs (preDSCs) are located around the vessels, and based on their antigen phenotype, previous studies suggested
a relationship between preDSCs and mesenchymal stromal/stem cells (MSCs). This work aimed to further elucidate
the MSC characteristics of preDSCs.
Methods: We established 15 human preDSC lines and 3 preDSC clones. Physiological differentiation (decidualization)
of these cell lines and clones was carried out by in vitro culture with progesterone (P4) and cAMP. Decidualization was
confirmed by the change in cellular morphology and prolactin (PRL) secretion, which was determined by enzyme
immunoassay of the culture supernatants. We also studied MSC characteristics: (1) In mesenchymal differentiation,
under appropriate culture conditions, these preDSC lines and clones differentiated into adipocytes, osteoblasts, and
chondrocytes, and differentiation was confirmed by cytochemical assays and RT-PCR. (2) The expression of stem cell
markers was determined by RT-PCR. (3) Cloning efficiency was evaluated by limited dilution. (4) Immunoregulatory
activity in vivo was estimated in DBA/2-mated CBA/J female mice, a murine model of immune-based recurrent
abortion. (5) Survival of preDSC in immunocompetent mice was analyzed by RT-PCR and flow cytometry.
Results: Under the effect of P4 and cAMP, the preDSC lines and clones decidualized in vitro: the cells became rounder
and secreted PRL, a marker of physiological decidualization. PreDSC lines and clones also exhibited MSC characteristics.
They differentiated into adipocytes, osteoblasts, and chondrocytes, and preDSC lines expressed stem cell markers OCT-
4, NANOG, and ABCG2; exhibited a cloning efficiency of 4 to 15%; significantly reduced the embryo resorption rate
(P < 0.001) in the mouse model of abortion; and survived for prolonged periods in immunocompetent mice. The fact
that 3 preDSC clones underwent both decidualization and mesenchymal differentiation shows that the same type of
cell exhibited both DSC and MSC characteristics.
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Conclusions: Together, our results confirm that preDSCs are decidual MSCs and suggest that these cells are involved
in the mechanisms of maternal–fetal immune tolerance.
Keywords: Clone cells, Decidua, Immune tolerance, Immunotherapy, Mesenchymal stromal cells, Predecidual stromal
cells, Recurrent abortion
Background
Decidual stromal cells (DSCs), which constitute the main
cellular component of human decidua, show activities that
appear to play an important role in the embryo implant-
ation [1], development of pregnancy [2], and maternal–
fetal immune tolerance [3–7]. These cells originate from
perivascular fibroblastic precursors, which are detected in
the gestational (decidua) as well as the nongestational
endometrium [8, 9]. Under the effect of ovarian hormones,
these DSC precursors leave the vessels and differentiate
into decidualized cells, which then spread throughout the
stroma in the late luteal phase (decidualization). Decidua-
lized cells change from a fibroblastic to a rounder shape
and secrete prolactin (PRL) [10–12]. These differentiated
cells are discarded during menstruation; however, if preg-
nancy takes place, the decidualization process continues
because of the effect of pregnancy hormones [8, 9].
Olivares et al. [13] introduced the term “predecidual stro-
mal cells” (preDSCs) to designate the precursors of DSCs,
and this term was later used by other authors [10, 14–16].
PreDSCs can be isolated from both the endometrium and
decidua and cultured in vitro. Moreover, they decidualize,
as in vivo, when incubated with progesterone (P4) and
cAMP, changing to a rounder cell shape and secreting
factors which are considered distinctive markers of decid-
ualization, including PRL [13, 17].
The isolation and maintenance of highly purified hu-
man preDSC lines in culture allowed us to analyze the
antigen phenotype of these cells and study their func-
tions [3–5, 18, 19]. Based on the perivascular location of
preDSCs, together with their expression of pericyte
markers and angiogenic factors, their phagocytic activity,
and their capacity to contract in vitro, we demonstrated a
close relationship between preDSCs and pericytes [19], con-
tractile cells that surround microvascular endothelial cells
[20, 21]. Furthermore, experimental evidence showed
strong similarities between pericytes and mesenchymal
stromal/stem cells (MSCs), and some have proposed that
they constitute the same cell population [22–24]. In this
connection, we previously confirmed that the antigen
phenotype of preDSCs is compatible with MSCs [5, 19, 25].
Functions such as cell contractility, resistance to apoptosis,
and inhibition of lymphocyte apoptosis are also shared by
MSCs and preDSCs [18, 26–30]. Further evidence of a
close relationship between preDSCs and MSCs was also
reported by Dimitrov et al. [31].
Mesenchymal stromal/stem cells exhibit immunoregu-
latory activities in vivo and in vitro that show promise in
the treatment of inflammatory and autoimmune diseases
[32]. Therefore, to further elucidate the relationship
between preDSCs and MSCs, the present study was de-
signed to investigate the in vivo effects of preDSC lines
in a murine model of immune system-mediated human
recurrent spontaneous abortion. This is a well-known
model in which CBA female mice are mated to DBA2
male mice, and pregnant CBA/2 animals have a high in-
cidence of embryo resorption. Different immune cells
and immunological mechanisms are involved in this
resorption [33, 34]. We considered this murine model
appropriate to investigate both the potential regulatory
effect of preDSCs in immune-based human recurrent




For the preDSC lines, samples from elective vaginal termi-
nations of first-trimester pregnancies (6–11 weeks) were
collected from 15 healthy women aged 20–30 years. We
excluded women who were using any medication or with
infectious, autoimmune, or other systemic or local disease.
None of the abortions was pharmacologically induced.
The specimens were obtained by suction curettage at the
Clínica El Sur in Málaga or the Clínica Ginegranada in
Granada. For the 3 human foreskin fibroblast (HFF) lines,
foreskin samples were obtained from patients at the
Hospital Universitario San Cecilio in Granada.
Isolation and culture of preDSC and HFF lines
We used the preDSC lines obtained in recent work as re-
ported earlier [19]. These lines consisted of a highly puri-
fied, uniform, adherent cell population in which almost all
cells expressed the endometrial stromal cell marker CD10
[35], together with CD13, CD29, CD44, CD73, CD90,
CD105, α-smooth muscle (SM) actin, nestin, podoplanin,
and vimentin, and lacked CD15, CD19, CD34, CD45,
CD62P, and HLA-DR expression. This antigen phenotype
is fully compatible with that of bone marrow MSCs [19,
36] (Table 1). To establish HFF lines from the human
foreskin, we used the method described by Kimatrai and
colleagues [28] to establish preDSC lines from the de-
cidua. Briefly, foreskin samples were minced between two
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scalpels in a small volume of PBS. The suspension was
mixed with a solution of 5 mg/mL collagenase V
(Sigma-Aldrich, St. Louis, MO, USA) for 30 min at
37 °C. The suspension was diluted in PBS and centrifuged
at 425g for 10min. The cell pellet was suspended in PBS
and centrifuged on Ficoll-Paque (Sigma-Aldrich) for 20min
at 600g. Foreskin cells were collected from the interface,
suspended in PBS, and washed. The resulting suspension
was incubated in culture flasks for 24 h at 37 °C with
5% CO2 in Opti-MEM (minimum essential medium)
(Invitrogen, Grand Island, NY, USA) supplemented
with 3% fetal calf serum (FCS) (Invitrogen), 100 IU/mL
penicillin, 100 μg/mL streptomycin, and 0.25 μg/mL
amphotericin (Sigma-Aldrich). After overnight incu-
bation to allow adherent cells to attach to the flask,
nonadherent cells in the supernatant were discarded.
The medium was then replaced and changed there-
after twice a week. After 1–3 weeks, adherent cells were
morphologically uniform and covered the whole surface of
the 25-cm2 culture flask. Cells were split with a trypsin-
EDTA solution of 0.25% (Sigma-Aldrich) when they were
90 to 100% confluent. Although the different cell lines are
referred to generically as preDSCs or HFFs, in experiments
with several lines of the same type of cell, we used a spe-
cific designation for each line (e.g., preDSC1, preDSC2).
For this study, 15 preDSC and 3 HFF lines were obtained
(each from a different sample) and were always used be-
tween 3 and 8 weeks after collection (up to 5 passages).
The maternal origin of each preDSC line was confirmed
by comparison with its corresponding trophoblast ob-
tained from the same sample, using short tandem repeat
markers and quantitative-fluorescent PCR (Devyser AB,
Hägersten, Sweden).
Cell cloning
We used three preDSC clones obtained in earlier work
[19]. Predecidual stromal cell clones were obtained from
preDSC lines by limiting dilution in 96-well plates, using
complete Opti-MEM supplemented with 10% FCS.
Three days after cell seeding, the plates were checked
and wells with only one cell were selected. After 2 weeks,
single cells had formed colonies which we then trypsi-
nized and seeded into 24-well plates for culture in
complete Opti-MEM supplemented with 3% FCS.
Decidualization
To induce decidualization, preDSC lines or clones
were treated with 300 nM P4 and 500 μM dibutyryl
cAMP (Sigma-Aldrich) for 15 days. Decidualization
was verified by PRL secretion and changes in cell
morphology from a fibroblastic to a round shape, as
observed with light microscopy. The presence of PRL
was verified with an electrochemiluminescence im-
munoassay (Roche, Indianapolis, IN, USA). The assays
were performed according to the manufacturer’s in-
structions, and all samples were tested in duplicate.
Mesenchymal differentiation
For osteogenic differentiation, preDSCs were plated on a
fresh tissue culture dish at 80 to 90% confluency in
Opti-MEM. The cells were allowed to attach for a mini-
mum of 24 h and rinsed with PBS. Complete osteogenic
differentiation medium (Opti-MEM supplemented with
10 nM ascorbic acid, 10 nM β-glycerol phosphate, 100
nM dexamethasone [Sigma-Aldrich], and 3% FCS) was
added, and the cells were incubated at 37 °C with 5%
Table 1 Antigen expression by preDSC and bone marrow MSC
lines obtained in the same conditions [19, 36]
































aAntigens expressed by more than 95% of cells
bAntigens meeting the minimal criteria for identification as MSC [37]
cSome lines expressed the antigen and some did not
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CO2 with humidity. Every 3 days, the medium was re-
placed with fresh complete osteogenic differentiation
medium. Osteogenesis required approximately 21–28
days and was verified by the formation of tightly packed,
elongated osteoblasts. In addition, the mineralized matrix
was detected by alizarin staining (Sigma-Aldrich). For
adipogenic differentiation, cells were plated on 5% FCS-
Opti-MEM in culture dishes and incubated at 37 °C in 5%
CO2. Two days after confluency, the cells were stimulated
with induction medium consisting of 100 μM 3-isobutyl-
1-methylxanthine, 1 μM dexamethasone, 100 μM indo-
methacin (Sigma-Aldrich), and 10 μg/mL insulin (Novo
Nordisk, Bagsvaerd, Denmark). Full differentiation was
usually achieved by day 15. Lipid droplets were visualized
with oil red O solution (Sigma-Aldrich). For chondrogenic
differentiation, adherent cell colonies were trypsinized and
counted, and the medium was replaced with serum-free
Opti-MEM supplemented with 10 ng/mL TGF-β1 (Sigma-
Aldrich). Aliquots of 2 × 105 cells in 1mL medium were
then centrifuged in conical polypropylene tubes. The pel-
leted cells were incubated at 37 °C in 5% CO2. Within 24 h
after incubation, the cells formed an aggregate that did
not adhere to the walls of the tube. The medium was
changed every 2 or 3 days, and the cell aggregates were
obtained at intervals of up to 21 days. To detect proteogly-
cans, 4-μm-thick frozen sections of aggregates were
stained with safranin O solution (Sigma-Aldrich).
Colony-forming unit test
Briefly, preDSCs were plated (100 cells/cm2) in 6-well
plates with 2 mL Opti-MEM supplemented with 3%
FCS, 100 IU/mL penicillin, 100 μg/mL streptomycin, and
0.25 μg/mL amphotericin. The plates were incubated at
37 °C with 5% CO2 for 15 days. Colonies were monitored
daily with light microscopy to verify they were derived
from single cells. The colonies were stained with 0.1%
crystal violet (Sigma-Aldrich) for 5 min at room
temperature and washed with distilled water. Only col-
onies with more than 50 cells were counted. The percent
cloning efficiency (CE) was calculated with the following
formula: CE (%) = number of colonies/number of cells
seeded.
Reverse transcription polymerase chain reaction
The primers used in this study, all from the Instituto de
Parasitología y Biomedicina, Granada, Spain, are detailed in
Table 2. Octamer-binding transcription factor 4 (OCT-4)
primers were obtained from Integrated DNA Tech-
nologies (Leuven, Belgium). To distinguish bona fide
OCT-4 transcripts from pseudogene transcripts, we
performed RT-PCR assays with two different forward
primers and one intron-spanning reverse primer (Oct4R).
One of the forward primers (Oct4FP) recognizes an exclu-
sive polymorphism of OCT-4, which makes it possible to
distinguish its corresponding transcript from pseudogene
transcripts. The other forward primer (Oct4F) recognizes
a nonhomologous region of pseudogenes [38].
Total RNA was extracted from cells with the TRIzol
isolation method, and cDNA was synthesized with
Oligo-dT primers and Moloney murine leukemia virus
H minus ribonuclease reverse transcriptase (Invitrogen)
according to the manufacturer’s protocol. For RT-PCR,
we used a 2720 Thermal Cycler (Applied Biosystems,
Darmstadt, Germany). The reaction mixture (total vol-
ume 20 μL) contained cDNA (equivalent of 100 ng
RNA), 200 nM deoxy-NTPs (Biotools, Madrid, Spain),
800 nm of each primer, and 0.5 U GoTaq polymerase
(Biotools). After incubation for 3 min at 95 °C, each cycle
consisted of 95 °C for 30 s, 55 °C for 45 s, and 72 °C for 45 s,
for a total of 35 cycles. The RT-PCR products were size-
separated on ethidium bromide-stained 2% agarose gels
(PanReact AppliChem, Barcelona, Spain), and a 100-bp
DNA ladder was included in each run.
Plasmids, lentiviral constructs, vector production,
titration, and preDSC transduction
The HIV packaging (pCMVΔR8.91) and the vesicular
stomatitis virus G glycoprotein (VSVg) (pMD.G) plas-
mids were kindly provided by D. Trono (University of
Geneva, Geneva, Switzerland). The packaging plasmid
Table 2 Primer sequences used for RT-PCR


















































F forward, R reverse
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pCMVΔR8.91 encodes gag, pol, tat, and rev genes.
The pMD.G plasmid encodes VSVg. The CEWP lenti-
viral vectors express an enhanced green fluorescent
protein (GFP) through the cytomegalovirus (CMV)
promoter [39]. Lentiviral vectors were produced by
cotransfection of 293T kidney cells (human embryonic
kidney cells, CRL-11268, ATCC) as previously described
[40]. Briefly, the three plasmids encoding the vector gen-
ome (CEWP), the gag-pol-tat-rev proteins (packaging
plasmid- pCMVΔR8.91), and the envelope glycoprotein
(pMD.G) were transfected into 293T cells with Lipofecta-
mine 2000 (Invitrogen). Viral supernatants were collected
and filtered through a 0.45-μm filter. Vector particles were
concentrated by ultrafiltration at 2000×g, 4 °C with 100-
kDa centrifuge filter devices as previously described [41]
(Amicon Ultra-15, Millipore, Billerica, MA, USA). Vector
supernatants were immediately frozen at − 80 °C or used
to transduce preDSCs. Briefly, preDCSs were detached
from the culture flask, washed with PBS, resuspended in
vector supernatant at a multiplicity of infection of 10, and
left in the incubator for 5–6 h. The viral supernatant was
removed and replaced with fresh Opti-MEM culture
medium. Four to 6 days later, the CEWP-transduced
preDSCs were analyzed by FACS for GFP expression.
The antigen phenotype, cell viability, and proliferation
of transduced preDSCs were equivalent to those of
nontransduced preDSCs.
Mice
Eight- to 10-week-old BALB/c, DBA/2, and CBA/J mice
(Janvier Labs, Le Genest-Saint-Isle, France) were housed
in our center’s animal facility (Centro de Investigación
Biomédica, Universidad de Granada) in stable humidity
and temperature conditions on a 12:12-h light/dark
cycle, with free access to food and water. All necessary
steps were taken to ensure maximum comfort of the an-
imals and compliance with current regulations on the
maintenance and use of experimental animals.
Murine model of recurrent abortion
Virgin female CBA mice were mated to male BALB/c
mice (control mating combination) or DBA2 male mice
(abortion-prone mating combination). For each combin-
ation, we established three groups: control PBS (intraperito-
neal injection of 0.5mL PBS), control HFFs (intraperitoneal
injection of 106 HFFs in 0.5mL PBS), and preDSC (intra-
peritoneal injection of 106 preDSCs in 0.5mL PBS). HFFs
were used in these experiments as a negative control for
preDSCs, because both types of cell are fibroblastic cells.
Pregnancy was verified by the presence of a vaginal plug
(gestation day 0.5), and 1.5 days later, we injected PBS or
preDSCs. The animals were killed on day 14 of gestation,
and the number of embryo implants and embryo resorp-
tions was recorded in each pregnant mouse. The results
were expressed as resorption rate: the percentage of reab-
sorbed embryos (no embryo in the implantation site) re-
ferred to the total number of implanted embryos.
Detection of human preDSCs in the mice tissues
The presence of preDSCs after intraperitoneal injection
in pregnant CBA/J mice in the murine model of recur-
rent abortion was determined by RT-PCR with human B
cytochrome (Cyt B) primers for human mitochondrial
DNA. Pellets (0.5mL) of centrifuged blood or small pieces
of dispersed spleen tissue were suspended in 0.5mL of a
solution of 0.1M EDTA and 50Mm TRIS (pH = 8) con-
taining 0.5% SDS and 1mg/mL proteinase K (Roche,
Roche Diagnostics, Basel, Switzerland) and incubated
overnight at 55 °C. Fifty microliters of a 3-M sodium acet-
ate solution (pH 7) and then 0.5mL of a phenol-
chloroform (1:1) solution were added. The samples were
vortexed and centrifuged at 16,200g for 5 min at room
temperature. Four hundred microliters of the upper aque-
ous phase was collected and mixed with 350 μL isopropa-
nol, and the mixture was centrifuged at 16,200g for 5min
at room temperature. The supernatant was discarded, and
the pellet was washed with absolute ethanol at 16,200g for
5min at room temperature. The supernatant was again
discarded, and the pellet was suspended in milliQ water
and incubated overnight at 55 °C. Polymerase chain reac-
tion was done with a 2720 thermal cycler (Applied Biosys-
tems). The PCR mixture contained 800 ng DNA, 200 μM
dNTPs, and 10 μM of each primer in a total volume of
50 μL. The PCR reactions were run with an initial step at
95 °C for 10min followed by 35 cycles at 94 °C for 1 min,
60 °C for 1min, and 72 °C for 1min.
We also injected 106 CEWP-transduced preDSCs sus-
pended in PBS intraperitoneally in virgin female BALB/c
mice. The animals were killed on different days, and the
blood, spleen, and inguinal lymph nodes were collected.
Blood was diluted in PBS and centrifuged on Ficoll-
Paque (Sigma-Aldrich). Lymph node and spleen tissues
were disaggregated with 5 mg/mL collagenase V (Sigma-
Aldrich) for 30 min at 37 °C, washed, suspended in PBS,
and centrifuged on Ficoll-Paque (Sigma-Aldrich). Cells
were collected from the interface, suspended in PBS, and
analyzed in a FACScan cytometer (BD Biosciences, San
Diego, CA, USA). Tissues from BALB/c mice in which
nontransduced preDSCs had been injected were used as
the negative control for flow cytometry.
Statistical analysis
The figures illustrate the results for a single experiment
representative of three or more separate assays. All experi-
ments were done in triplicate or quadruplicate. The Wil-
coxon test was used to compare the results for the changes
in morphology and PRL secretion. To study recurrent
abortion, the results were analyzed with the chi-squared
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test corrected for a cluster sampling design (Rao–Scott
correction) [42], as uncorrected chi-squared or Fisher’s
exact tests, used by other authors, may yield misleading
results. Values of P < 0.05 were considered significant.
Results
MSC characteristics of preDSC lines
The preDSC lines were composed of a highly purified
uniform population of proliferating fibroblast-shaped
adherent cells [19]. These cells exhibited an antigen
phenotype compatible with that of MSCs [19, 36]
(Table 1). In cultures with cAMP and P4, preDSC lines
decidualized, changing their morphology from a fibro-
blastic to a rounder shape and secreting PRL (Fig. 1a).
Furthermore, by RT-PCR, we detected the pluripotent
stem cell markers OCT-4, NANOG, and ABCG2 in
preDSCs (Fig. 1b)—markers also associated with MSCs
[43]. Detecting OCT-4 transcripts by RT-PCR is always
a challenge, since artifacts are easily induced by the ampli-
fication of many OCT-4-like transcripts originating from
the expression of processed and nonprocessed pseudo-
genes. Both forward primers, i.e., OCT-4-specific OCT-
4FP and OCT-4F, which also amplifies pseudogenes, were
positive in all 4 preDSC lines. The colony-forming effi-
ciency of the preDSC lines ranged between 4 and 15%
(Fig. 1c). Under appropriate culture conditions, preDSCs
differentiated into the three different mesenchymal line-
ages—adipocytes, osteoblasts, and chondrocytes—as con-
firmed by cytochemical assays and RT-PCR (Fig. 1d).
PreDSC clones exhibited both DSC and MSC
characteristics
Three preDSC clones showed an antigen phenotype
equivalent to that expressed by preDSC lines, and also
compatible with that of bone marrow MSC [19, 36].
When these three clones were cultured with P4 and
cAMP, they also changed their cell morphology toward a
rounder shape and secreted PRL. Under appropriate
conditions, these three clones also differentiated into
adipocytes, chondrocytes, and osteoblasts (Fig. 2). These
results demonstrated that the same type of cell can
undergo decidual or mesenchymal differentiation.
PreDSC lines reduced the resorption/implantation ratio in
the abortive mating combination female CBA/J ×male
DBA/2
To study the in vivo immunoregulatory activity of
preDSCs, we injected these cells in the abortion-prone
mating combination CBA/J♀ ×DBA/2♂. As expected, in
this combination, the resorption/implantation ratio was
significantly higher than in the nonabortion-prone mating
combination CBA/J♀ × BALB/c♂ (P < 0.01). The injection
of preDSCs in the abortion-prone mating combination led
to a significant reduction in the resorption/implantation
ratio (P < 0.001), whereas control HFFs increased this ra-
tio, although not significantly. The injection of preDSCs
and HFFs in the control mating combination had no
significant effect (Fig. 3a, Additional file 1: Table S1).
Detection of human preDSCs injected in
immunocompetent mice
The results with RT-PCR for the human marker Cyt B
confirmed the presence of preDSCs on day 14 of gesta-
tion, i.e., 12 days after the injection of human preDSCs
in both control and experimental animals in the murine
model of recurrent abortion. These cells were detected
in the blood, in the spleen from BALB/c-mated pregnant
CBA/J mice, and in the spleen of DBA/2-mated preg-
nant CBA/J mice (Table 3). Blood and spleen samples
from CBA/J mice in which preDSCs were not injected
were all negative for human Cyt B, but all samples were
positive for murine Cyt B (Fig. 3b). Although human Cyt
B might have been detected in murine macrophages that
could have phagocytosed preDSCs, it is highly unlikely
that preDSC mitochondrial DNA would survive in mac-
rophages for up to 12 days after human preDSCs were
injected.
We also confirmed the presence of live preDSCs in
virgin female BALB/c mice by injecting GFP-labeled
preDSCs. These cells were detected by flow cytometry in
the blood after 2 days and in the inguinal lymph nodes
after 45 days. Thirty days after the injection, preDSCs
appeared to be present in the spleen. PreDSCs were not
found in the blood after 45 days, in the inguinal lymph
nodes after 2 days, or in the spleen after 2 days (Fig. 4,
Table 3). Because the degradation half-life of GFP is only
a few hours [44], the detection of this protein in cells
days and weeks after the injection in the mice indicates
active GFP synthesis by preDSCs that remain alive.
The aim of these experiments was not to establish a
precise dynamic of the diffusion of preDSCs in different
tissues and organs but to confirm the ability of these
cells to survive in the short, middle, and long term in
immunocompetent mice. In general, our results showed
that preDSCs survived in the blood in the short term (2
days) and in the middle term (12 days) in 100% of mice,
but these cells disappeared from this tissue in the long
term (45 days). In the lymph nodes and spleen, preDSCs
were not detected in the short term; however, these cells
were found in the middle (in 2 of out 6 mice) and long
term (1 of out 3 mice) in spleen tissue. In all, preDSCs
survived in 10 of out 27 mice (Table 3).
Discussion
Our preDSC lines consisted of a highly purified, uni-
form, adherent cell population. Under the effects of
cAMP and P4, these cells displayed the physiological
differentiation pathway (decidualization) of DSCs: their
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morphology changed from a fibroblastic to a rounder
shape, and they began to secrete PRL (Fig. 1a) [8–13].
Furthermore, the antigen phenotype of these preDSC
lines was previously studied and found to be fully
compatible with that of bone marrow MSCs [5, 19]
(Table 1). This antigen phenotype, together with the ad-
herence of preDSCs to plastic culture dishes and their
capacity to differentiate into adipocytes, osteoblasts, and
Fig. 1 Characteristics of preDSC lines. a Decidualization. After 14 days of culture with P4 and cAMP, undifferentiated preDSCs (Undif.) changed
from a fibroblastic to a rounder shape (left) and secreted PRL (right). The bars show the percentage of round cells and the secretion of PRL by a
preDSC line (mean ± SD of three independent determinations). Scale bar, 50 μm. b Detection by RT-PCR of pluripotent stem cell markers in four
preDSC lines. c Cloning efficiencies of the three preDSC lines. d Mesenchymal differentiation of a preDSC line. Undifferentiated preDSCs (undif.),
osteogenic (ost.), adipogenic (adip.), and chondrogenic (chond.) differentiated preDSCs. Differentiation was documented with alizarin staining
(ost.), oil red O solution (adip.), and safranin O (chond.). Scale bar, 50 μm. Molecular markers of differentiation were detected by RT-PCR: PPARγ2
(adip.), collagen type II (chond.), osteopontin, and AP (ost.). AP and osteopontin were also positive in undifferentiated preDSC lines [25, 28]. Beta-2
microglobulin (B2MG) was used as the loading control. The bars represent mean ± SD of three independent determinations. These experiments
were done in 4 independent replications. *P < 0.001, **P < 0.0005
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chondrocytes (Fig. 1d), are properties that, taken together,
meet the minimal criteria proposed by the International So-
ciety for Cellular Therapy (ISCT) to define human MSCs
[37]. The possibility that these MSC and DSC properties
were due to the presence of different cell subpopulations in
our preDSC lines was ruled out. The facts that all three of
the preDSC clones we obtained exhibited an antigen
phenotype like that of preDSC lines [19], and therefore
equivalent to that of MSCs, and underwent mesenchymal
and decidual differentiation (Fig. 2) demonstrate that single
type of cell, i.e., preDSCs, exhibited both DSC and MSC
characteristics. Other MSC features are the expression
of stem cell markers, clonogenicity, and immunoregula-
tory activities [32]. Likewise, preDSC lines expressed
the multipotentiality markers OCT-4, NANOG, and
ABCG2, their clonogenic efficiency ranged between 4
and 15% (Fig. 1), they remained alive for weeks in xeno-
geneic transplants (Fig. 4), and they had a therapeutic
effect in an immune-based murine model of spontan-
eous abortion (Fig. 3). Taken together, these findings
confirm the close relationship between bone marrow
MSCs and preDSCs (Table 4).
Fig. 2 Three preDSC clones exhibited both decidual and mesenchymal characteristics. All three clones were able to decidualize (i.e., to show
morphological changes and secrete PRL) and differentiate into osteoblasts, chondrocytes, and adipocytes. Bar graphs show the percentage of round
cells and the secretion of PRL by each of the three clones (mean ± SD of three independent determinations per clone). Mesenchymal differentiation
was documented with alizarin staining (osteogenic), oil red O solution (adipogenic), and safranin O (chondrogenic). Scale bar, 50 μm. These
experiments were done in 4 independent replications. *P < 0.001, **P < 0.005, ***P < 0.0001, ****P < 0.00005. Undifferentiated preDSC clone (Undif.)
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Dimitrov et al., also using human preDSC lines, found
an association between these cells and MSCs [31]. This
connection suggests that MSCs home to the nongesta-
tional endometrium or the decidua to develop into
preDSCs. This possibility is supported by the finding of
endometrial cells of donor origin in the uterus of women
who received bone marrow transplants [50].
A single-cell transcriptomics approach was used by
Vento-Tormo et al., who identified different cell types in the
first-trimester human placenta. The cellular composition of
Fig. 3 PreDSCs inhibited the resorption rate in the abortion-prone CBA/J♀ × DBA/2♂ combination. preDSCs, HFFs, or PBS were injected on day 2
of gestation in CBA/J mice mated to DBA/2 mice or control BALB/c mice, and the rate of embryo resorption (percentage of reabsorbed embryos
referred to the total number of embryo implantations) was determined on day 14 of gestation. a The resorption rate (mean ± SD) was
significantly higher in the abortion-prone CBA/J♀ × DBA/2♂ combination than in the control CBA/J♀ × BALB/c♂ combination (*P < 0.01). The
injection of preDSCs significantly decreased the abortion rate in CBA/J♀ × DBA/2♂ matings (**P < 0.001). The injection of HFFs increased the
abortion rate, but not significantly. b PreDSCs were detected by human Cyt B PCR in the blood and spleen of BALB/c-mated pregnant CBA/J
mice and in the spleen of DBA/2-mated pregnant CBA/J mice in which preDSCs were injected. None of the control mice, in which preDSCs were
not injected (PBS), was positive. Murine Cyt B PCR was positive in all samples
Table 3 Detection of preDSCs in tissues of immunocompetent mice in which human preDSCs were injected
Strain Cells injected/method of detection Blood Lymph nodes Spleen
CBA/J PreDSCs/RT-PCR Day 12a: 3/3b ND Day 12: 2/6c








b3 positive mice out of 3
c1/3 DBA/2-mated pregnant CBA/J and 1/3 in BALB/c-mated pregnant CBA/J
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human decidua includes the presence of perivascular
cells, with an antigen phenotype (CD146+ CD140b+,
W5C5+, α-SM actin+, CD29+, ANGPT1+, and VCGFA+)
consistent with that reported by us for preDSCs, cells that
also exhibit a perivascular location (Table 1) [19, 51]. We
demonstrated the close relationship between human
preDSCs and pericytes [19], the latter also being a perivas-
cular cell type closely associated with—possibly even
identical to—MSCs [22–24]. PreDSCs also appear to cor-
respond to the MSCs in the human endometrium reported
by other authors (endometrial MSCs, eMSCs), i.e., clono-
genic, self-renewing, multipotent cells that can differentiate
Fig. 4 Detection of preDSCs in tissues of mice in which human preDSCs were injected. Human preDSCs transduced with GFP (preDSC-GFP) and
injected in BALB/c female mice were detected by flow cytometry in the blood 2 days after the injection and in the inguinal lymph nodes after
45 days. Thirty days after the injection, preDSCs appeared to be present in the spleen although this observation was not conclusive. As a control,
we used BALB/c mice in which nontransduced preDSCs were injected
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into adipogenic, osteogenic, chondrogenic, and myo-
genic lineages [52]. Like preDSCs, eMSCs are CD146+,
CD140b+, and W5C5+, decidualize, are found in perivas-
cular sites, and have also been associated with pericytes
[19, 53–56]. However, eMSCs were isolated by cell sorting
from nongestational endometrium samples, whereas the
preDSC lines we obtained from the decidua were enriched
by cell culture [19].
Bone marrow or fat MSCs exert immunoregulatory ac-
tivities that support therapeutic effects against inflam-
matory and autoimmune diseases [32]. In the present
study, we show that preDSCs survived in xenogeneic
transplants in vivo for prolonged periods in immuno-
competent mice (Fig. 4). This result is consistent with
the findings that demonstrated the long-term survival of
human MSCs in immunocompetent mice [47] and rats
[48]. Although the immunological mechanisms involved
in our in vivo experiments were not studied, several
lines of experimental evidence confirm that MSCs func-
tion across species barriers [57]. In this connection, it
has been shown before that human DSCs can interact
with the rat and mouse immune systems [58, 59]. The
expression of HLA-G and the secretion of IL-10 by
preDSCs [3] may be additional mechanisms involved in
the induction of tolerance and escape from the immune
response in xenotransplants [60, 61]. Other immunoreg-
ulatory properties, such as the induction of T regulatory
cells (Tregs), detected in MSCs and DSCs [62, 63], and
our own unpublished data, may explain the escape from
immune rejection in allo- and xenotransplants. In this
connection, it was proposed that MSCs play a key role in
the physiological mechanisms of immune self-tolerance
[23]. Likewise, preDSCs play a role in local mechanisms of
maternal–fetal immune tolerance that support normal
pregnancy [3, 18]. The abortion-prone mating of female
CBA/J mice with male DBA/2 mice is an animal model of
human immunologically mediated spontaneous abortion
in which the maternal–fetal immune tolerance has broken
down [33, 34]. We considered this murine model appro-
priate to investigate both the potential regulatory effect of
preDSCs in immune-based human recurrent abortion and
the role of preDSCs in maintaining maternal–fetal im-
mune tolerance. This hypothetical function of preDSCs is
supported by our finding that the injection of preDSCs in
CBA/J females mated to DBA males significantly de-
creased the embryo resorption rate (Fig. 3, Additional file 1:
Table S1). Similarly, syngeneic murine fat MSCs were
shown to be therapeutically effective in this model [64].
Other reports have also documented the beneficial effects
of human DSCs in steroid-refractory graft-versus-host
disease in humans [65, 66], a finding that identifies DSCs
as a potentially important component of cell therapies for
immune-mediated diseases. In this connection, the avail-
ability of purified, expandable preDSC lines may help to
facilitate further research on the clinical applications in
the treatment of inflammatory and autoimmune diseases.
Conclusions
Our data show that preDSCs are decidual MSCs that ex-
hibit immunoregulatory activities that may be relevant
in the decidual mechanisms of maternal–fetal immune
tolerance. These cells may also be beneficial in the treat-
ment of immune-mediated diseases.
Additional file
Additional file 1: Table S1. Effect of preDSCs on the embryo
resorption rate in the abortion-prone CBA/J × DBA/2 combination and
control CBA/J × BALB/c combination. (DOC 30 kb)
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